Closed
SectorHealthcare
126.64 -0.86
24h
Min
125.96
Max
128.1
Income | -95M 7.9M |
---|---|
Sales | -55M 573M |
P/E Sector Avg | 42.789 50.291 |
EPS | 0.7 |
Profit margin | 1.38 |
Employees | 1,800 |
EBITDA | -146M 24M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +25.41% upside |
Next Earnings | 31 Jul 2025 |
---|
Market Cap | 820M 12B |
---|---|
Previous open | 127.5 |
Previous close | 126.64 |
By Acuity
50%
50%
165 / 380 Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 160.25 USD 25.41%
High 192 USD
Low 115 USD
Based on 21 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$